The Rein in Sarcoma Foundation (RIS) has supported sarcoma research at the Masonic Cancer Center, University of Minnesota since 2001. Through the work of the Foundation, the sarcoma research program has grown from having seven clinical faculty devoted to treating sarcoma seven years ago, to twelve clinical faculty today.
In 2007, in collaboration with the Children’s Cancer Research Fund and the Roby Thompson Endowment in Musculoskeletal Oncology, KWRISF created a Translational Sarcoma Cancer Research Award to provide seed grants for new and innovative research, hoping the results will be carried forward for federal funding. Announced at Rein in Sarcoma 2008 on July 21, this year’s $50,0000 award recipient is again Subbaya Subramanian, Ph.D., who will be studying the molecular characterization of osteosarcoma through the profiling of microRNA.
Osteosarcoma is the sixth leading cancer in children and the most common bone cancer in teens who are experiencing a growth spurt. Dr. Subramanian’s research proposes that by studying the expression levels and interactions of mRNA and miRNA in osteosarcoma a genetic pattern could be discovered. This genetic knowledge may lead to novel therapeutics for the disease.
Subbaya Subramanian, Ph.D., Assistant Professor, Department Laboratory Medicine and Pathology University of Minnesota
Dr. Subramanian received his Ph.D. in molecular and cell biology in 2003 from the Center for Cellular and Molecular Biology, Jawaharlal Nehru University, India, and completed his post-doctoral fellowship at Stanford University, Stanford, California. He joined the faculty of the Department of Laboratory Medicine and Pathology at the University of Minnesota in 2007 and studies the molecular mechanisms of tumor development and progression.
For more information about other recent grants by the KWRISF for sarcoma cancer research, click here.